Why the study?
Does measurement of cord serum prebeta-beta-lipoprotein identify infants with familial type II hyperlipoproteinemia?
Population
303 randomly selected, full-term infants whose parental phenotypes were unknown
Design
Cohort
Authors
Loading...
May support cord blood screening to identify neonatal familial type II hyperlipoproteinemia; leaves open routine adoption pending validation in larger cohorts.
Does measurement of cord serum prebeta-beta-lipoprotein identify infants with familial type II hyperlipoproteinemia?
Cord serum prebeta-beta-lipoprotein measurement can identify familial type II hyperlipoproteinemia in neonates, provided transient hyperlipidemias are excluded.
ANDERSEN et al. (1976) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: